Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors

Table 4 Topic raised according to type of treatment

Topic	Treatment group	N (%)	Crude OR (95% CI)	P-value	Adjusted OR^a (95% CI)	P-value
Pain	SRT	13/64 (20)	1.0 (ref)		1.0 (ref)
Pain	MMT	33/96 (34)	2.1 (0.9–4.3)	0.06	2.1 (0.9–4.8)	0.07
Fatigue	SRT	13/64 (20)	1.0		1.0
Fatigue	MMT	50/96 (52)	4.3 (2.1–8.8)	< 0.001	4.3 (1.9–9.5)	< 0.001
Bowel/urination	SRT	1/64 (2)	1.0		1.0
Bowel/urination	MMT	6/96 (6)	4.2 (0.5–36)	0.19	5.4 (0.5–54)	0.15
Sexual	SRT	6/64 (9)	1.0		1.0
Sexual	MMT	14/96 (15)	1.7 (0.6–4.5)	0.33	1.3 (0.4–3.9)	0.68
Mobility	SRT	9/64 (14)	1.0		1.0
Mobility	MMT	27/96 (28)	2.4 (1.0–5.5)	0.04	2.4 (0.9–5.8)	0.06
Psychological	SRT	6/64 (9)	1.0		1.0
Psychological	MMT	13/96 (14)	1.5 (0.5–4.2)	0.42	1.0 (0.3–3.2)	0.96
Other	SRT	11/64 (17)	1.0		1.0	0.54
Other	MMT	12/96 (12)	0.7 (0.3–1.7)	0.41	05 (0.3–2.0)
Peer	SRT	3/64 (5)	1.0		1.0
Peer	MMT	7/96 (7)	1.6 (0.4–6.4)	0.51	2.0 (0.4–9.8)	0.36
No topic	SRT	11/64 (17)	1.0		1.0
No topic	MMT	9/96 (8)	0.5 (0.2–1.3)	0.15	0.4 (0.1–1.3)	0.14

N are presented as number of patients that raised the topic within the treatment group with % in the brackets
Italic values indicate significance of P-value (P < 0.05)
OR odds ratio, CI confidence interval, ref reference, SRT surgery/radiotherapy group, MMT multimodal therapy group
^aAdjusted for age and gender

ISSN: 2045-3329